News Powered By:
- a collaborative partner.
CenterWatch News Online Headlines : October 17, 2014 9:49 am : Centerwatch
Physicians are looking to pharmaceutical companies to help them keep patients engaged in their healthcare by providing patient services, according to the ePharma Physician 2014 study from Manhattan Research, part of Burlington, Mass.-based Decision Resources Group.
CenterWatch News Online Headlines : October 17, 2014 9:47 am : Centerwatch
As Apple, Samsung and Google field health and fitness data aggregators, 30% of online consumers would be interested in using such a service, and more than one-third would consider doing so if it saved them money.
CenterWatch News Online Headlines : October 17, 2014 7:49 am : Centerwatch
Cardiorentis, a Switzerland-based, privately held biopharmaceutical company, is collaborating with Roche to establish the therapeutic efficacy and safety of Ularitide, the company’s investigational drug for acute heart failure (AHF). Cardiorentis will incorporate Roche’s advanced in vitro diagnostic tests into its TRUE-AHF phase III study to characterize the pharmacological properties of Ularitide, evaluate its benefit-risk profile and the appropriate clinical application in patients.
CenterWatch News Online Headlines : October 17, 2014 7:48 am : Centerwatch
Immune Design, a California-based clinical-stage immunotherapy company, has entered into a broad collaboration for the development of a herpes simplex virus (HSV) immune therapy with Sanofi Pasteur, the vaccines division of Sanofi.
CenterWatch News Online Headlines : October 17, 2014 7:46 am : Centerwatch
AstraZeneca, together with its global biologics R&D arm MedImmune, has entered into four new collaborations with the University of Cambridge, building further on their existing partnership. The latest collaborations reinforce AZ’s commitment to creating a permeable research infrastructure in Cambridge following its decision to locate one of its three global R&D centers and its global headquarters in the city, which has been home to MedImmune’s biologics research laboratories for 25 years.